News Gentian Diagnostics

Equities

GENT

NO0010748866

Real-time Oslo Bors Other stock markets 07:41:58 2024-04-30 am EDT			5-day change	1st Jan Change
39 ^NOK	-2.01%		+3.72%	-6.02%

Apr. 29	Gentian Diagnostics Asa Resolves to Elect Ms. Hilja Ibert as Chairperson of the Board of Directors	CI
Apr. 29	Gentian Diagnostics ASA Appoints Mr. Njaal Kind as Acting CEO	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Gentian Diagnostics ASA, Q1 2024 Earnings Call, Apr 30, 2024	03:00am
Gentian Diagnostics : 30 April 2024 - Quarterly Presentation - Q1 2024	02:16am	PU
Gentian Diagnostics : 30 April 2024 - Quarterly Report - Q1 2024	02:16am	PU
Gentian Diagnostics Asa Resolves to Elect Ms. Hilja Ibert as Chairperson of the Board of Directors	Apr. 29	CI
Gentian Diagnostics ASA Appoints Mr. Njaal Kind as Acting CEO	Apr. 29	CI
Gentian Diagnostics: New acting CEO and Chairperson of the Board of Directors	Apr. 29	AQ
Gentian Diagnostics : Scientists to Gentian’s R&D department	Apr. 08	PU
Gentian Diagnostics ASA Announces Resignation of Hilja Ibert as CEO, Effective on April 29, 2024	Mar. 21	CI
Tomas Settevik Not to Stand for Re-Election as Chairperson of Gentian Diagnostics ASA, Effective April 29, 2024	Mar. 21	CI
Gentian Diagnostics' CEO Resigns, Wins Recommendation to Succeed Chair	Mar. 21	MT
Gentian Diagnostics ASA Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 09	CI
Transcript : Gentian Diagnostics ASA, Q4 2023 Earnings Call, Feb 09, 2024	Feb. 09
Gentian Diagnostics Asa Announces Resignation of Frank Frantzen from the Board of Directors	Dec. 18	CI
Gentian Diagnostics presents at the DNB Nordic Healthcare Conference	Dec. 14	AQ
Gentian Diagnostics ASA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-26	CI
Transcript : Gentian Diagnostics ASA, Q3 2023 Earnings Call, Oct 26, 2023	23-10-26
Gentian Diagnostics : Sales and Application Specialist - Nordic	23-10-10	PU
Gentian Diagnostics ASA Expands Product Portfolio With Turbidimetric Retinol-Binding Protein Immunoassay	23-09-29	CI
Gentian Diagnostics ASA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-24	CI
Transcript : Gentian Diagnostics ASA, Q2 2023 Earnings Call, Aug 24, 2023	23-08-24

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Gentian Diagnostics

Equities

GENT

NO0010748866

Summary

Filters